As 3D pathology continues to grow, understanding the benefits and drawbacks of the technology is increasingly important in deciding which diagnostic route to take. Lifesciences Intelligence took a deep dive with CEO Nick Reder to understand the implications, benefits, and challenges of 3D Pathology using Alpenglow’s innovative 3Deep technology platform.
